NTUS

NASDAQ:NTUS

Natus Medical Incorporated

  • Stock

USD

Last Close

32.96

01/01 00:00

Volume Today

132.70K

Avg: 339.69K

PE Ratio

84.22

PFCF: -

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
net income
22.88M
-
32.48M
41.96%
37.92M
16.77%
42.59M
12.31%
-20.29M
147.64%
-22.93M
13.02%
-15.67M
31.67%
-16.61M
6.01%
13.18M
179.32%
depreciation and amortization
12.85M
-
11.76M
8.48%
15.99M
35.96%
16.88M
5.58%
30.10M
78.32%
33.86M
12.51%
30.72M
9.28%
28.11M
8.49%
28.09M
0.09%
deferred income tax
stock based compensation
6.08M
-
6.06M
0.26%
6.95M
14.70%
9.01M
29.56%
9.45M
4.85%
17.05M
80.53%
8.35M
51.02%
9.57M
14.54%
14.16M
48.03%
change in working capital
-5.91M
-
-6.70M
13.51%
-29.13M
334.55%
178K
100.61%
-16.56M
9,405.62%
-27.82M
67.95%
7.17M
125.76%
-154K
102.15%
2.93M
2,005.19%
accounts receivables
9.36M
-
-2.43M
125.98%
-15.27M
528.22%
19.72M
229.14%
-30.47M
254.50%
-5.20M
82.94%
9.82M
288.82%
17.65M
79.80%
-13.11M
174.28%
inventory
-2.30M
-
-2.02M
12.23%
-12.23M
506.45%
-7.67M
37.31%
7.58M
198.87%
-7.44M
198.18%
7.18M
196.53%
1.94M
73.01%
4.83M
149.10%
accounts payables
-1.39M
-
-7.65M
451.41%
3.27M
142.76%
-4.96M
251.83%
-1.39M
72.10%
4.11M
396.39%
-1.37M
133.30%
-4.52M
230.87%
13.53M
399.14%
other working capital
-11.58M
-
5.39M
146.58%
-4.89M
190.75%
-6.91M
41.23%
7.71M
211.59%
-19.28M
350.01%
-8.47M
56.09%
-15.22M
79.75%
-2.31M
84.79%
other non cash items
898K
-
-1.45M
261.80%
5.12M
452.10%
4.03M
21.27%
17.04M
323.04%
32.86M
92.85%
29.49M
10.26%
13.51M
54.18%
5.63M
58.32%
net cash provided by operating activities
36.80M
-
42.14M
14.53%
36.85M
12.55%
72.69M
97.24%
19.73M
72.86%
33.02M
67.39%
60.06M
81.89%
34.43M
42.68%
63.99M
85.89%
investments in property plant and equipment
-3.70M
-
-5.72M
54.59%
-5.19M
9.20%
-3.40M
34.62%
-4.07M
19.73%
-8.54M
110.03%
-5.34M
37.48%
-8.61M
61.25%
-3.62M
57.95%
acquisitions net
-18.60M
-
-4.92M
73.52%
-14.28M
190.03%
-15.85M
10.96%
-190.89M
1,104.42%
151K
100.08%
-4.00M
-
-1M
74.98%
purchases of investments
-34.02M
-
sales maturities of investments
210K
-
34.02M
16,099.52%
other investing activites
-210K
-
2.67M
-
net cash used for investing activites
-22.30M
-
-10.64M
52.26%
-19.48M
82.98%
-53.26M
173.46%
-160.94M
202.15%
-8.39M
94.79%
-5.34M
36.36%
-12.61M
136.11%
-1.95M
84.56%
debt repayment
-52.23M
-
-38.02M
27.21%
-16M
-
-45M
181.25%
-50M
11.11%
-50.48M
0.96%
-58.53M
15.95%
-57.41M
1.91%
common stock issued
common stock repurchased
-4.63M
-
-11.53M
148.76%
-19.29M
67.37%
-2.27M
88.24%
-5.63M
148.24%
-10.49M
-
dividends paid
other financing activites
69.47M
-
21.74M
68.71%
12.36M
43.15%
153.71M
1,143.88%
53.09M
65.46%
6.12M
88.48%
1.95M
68.19%
58.15M
2,887.92%
-3.25M
105.59%
net cash used provided by financing activities
17.25M
-
-20.91M
221.26%
832K
103.98%
118.42M
14,132.81%
5.83M
95.08%
-49.51M
949.85%
-48.53M
1.98%
-10.88M
77.59%
-60.66M
457.71%
effect of forex changes on cash
1.30M
-
-132K
110.11%
-2.29M
1,638.64%
-6.76M
194.47%
10.78M
259.54%
-7.70M
171.38%
735K
109.55%
7.84M
966.94%
-7.87M
200.41%
net change in cash
33.05M
-
10.45M
68.37%
15.91M
52.23%
131.08M
723.85%
-124.60M
195.06%
-32.58M
73.85%
6.92M
121.25%
18.79M
171.30%
-6.49M
134.53%
cash at beginning of period
23.06M
-
56.11M
143.34%
66.56M
18.63%
82.47M
23.91%
213.55M
158.95%
88.95M
58.35%
56.37M
36.62%
63.30M
12.28%
82.08M
29.68%
cash at end of period
56.11M
-
66.56M
18.63%
82.47M
23.91%
213.55M
158.95%
88.95M
58.35%
56.37M
36.62%
63.30M
12.28%
82.08M
29.68%
75.59M
7.90%
operating cash flow
36.80M
-
42.14M
14.53%
36.85M
12.55%
72.69M
97.24%
19.73M
72.86%
33.02M
67.39%
60.06M
81.89%
34.43M
42.68%
63.99M
85.89%
capital expenditure
-3.70M
-
-5.72M
54.59%
-5.19M
9.20%
-3.40M
34.62%
-4.07M
19.73%
-8.54M
110.03%
-5.34M
37.48%
-8.61M
61.25%
-3.62M
57.95%
free cash flow
33.10M
-
36.42M
10.05%
31.66M
13.08%
69.29M
118.87%
15.66M
77.40%
24.48M
56.32%
54.72M
123.53%
25.82M
52.82%
60.38M
133.86%

All numbers in USD (except ratios and percentages)